Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study.

Date publication

octobre 2020

Journal

EClinicalMedicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOLOGNA Serge , Dr DAGUINDAU Etienne , Dr DRENOU Bernard , Dr ROSSI Cédric

Tous les auteurs :
Lamure S, Duléry R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, Noël N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thiéblemont C, Cartron G, Lacombe K, Besson C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33073216

Résumé

Patients with lymphoma are immunocompromised because of the disease and its treatments. We aimed to describe the characteristics of patients with lymphoma hospitalized for Coronavirus Disease 2019 (Covid-19) and to analyze pre-Covid-19 determinants of mortality.

Référence

EClinicalMedicine. 2020 Oct 13;:100549